# Edmund Claxton, MD – FDA Inspection, Dec 4, 2018

Source: https://www.keypedia.com/records/fda_inspections/edmund-claxton-md/bb920e33-23df-4a9f-8a5c-3c64ab719b17
Source feed: FDA_Inspections

> FDA inspection 1073398 of Edmund Claxton, MD, December 04, 2018. Classification: No Action Indicated (NAI). 3 citations under 21 CFR parts 50 and 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1073398
- Company Name: Edmund Claxton, MD
- Inspection Date: 2018-12-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Officers

- [Company Rep](https://www.keypedia.com/people/nina-yang/8d080437-2e05-4b75-8c53-b818d761cf1f)
- [Issuing Officer](https://www.keypedia.com/people/shirley-s-wen/eafbc8e5-a0ac-443a-adaf-ced505f77842)

Company: https://www.keypedia.com/companies/edmund-claxton-md/4a162a11-e62c-4761-951b-cbf7d8b79e04

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c